Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 12, 2022 Filed Aug 16, 2022 20:06 UTC |
TAI JACKSON PDirector
|
PurchaseCommon Stock | 656 | $304.19 | $199,548.64 |
DisclosureSEC source: 0000059478-22-000201 · wf-form4_166068036193577.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,857 Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:34 UTC |
Weems AlonzoSVP, ERM & CECO
|
GiftCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000198 · wf-form4_166033643803458.xml · nonDerivative · entry 2 Weems Alonzo · CIK 0001869672 · SVP, ERM & CECO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,606 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2022. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:34 UTC |
Weems AlonzoSVP, ERM & CECO
|
SaleCommon Stock | 656 | $304.50 | $199,752.00 |
DisclosureSEC source: 0000059478-22-000198 · wf-form4_166033643803458.xml · nonDerivative · entry 1 Weems Alonzo · CIK 0001869672 · SVP, ERM & CECO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,136 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2022. Read SEC document |
| July 28, 2022 Filed Jul 29, 2022 15:43 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 500 | $333.51 | $166,755.00 |
DisclosureSEC source: 0001209191-22-043434 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,875,441 Read SEC document |
| July 28, 2022 Filed Jul 29, 2022 15:43 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 88,958 | $332.85 | $29,609,759.26 |
DisclosureSEC source: 0001209191-22-043434 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,875,941 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.50 to $333.49 , inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 26, 2022 Filed Jul 27, 2022 14:26 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,601 | $332.52 | $532,370.92 |
DisclosureSEC source: 0001209191-22-043241 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,964,899 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.50 to $332.57, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 00:02 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 35 | $321.77 | $11,261.95 |
DisclosureSEC source: 0000059478-22-000180 · wf-form4_165827536063973.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,735 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 00:04 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 31 | $321.77 | $9,974.87 |
DisclosureSEC source: 0000059478-22-000182 · wf-form4_165827544709751.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,528 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 00:05 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 31 | $321.77 | $9,974.87 |
DisclosureSEC source: 0000059478-22-000184 · wf-form4_165827552636440.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 00:07 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 30 | $321.77 | $9,653.10 |
DisclosureSEC source: 0000059478-22-000186 · wf-form4_165827561551263.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,301 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 00:09 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 44 | $321.77 | $14,157.88 |
DisclosureSEC source: 0000059478-22-000188 · wf-form4_165827573308731.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,909 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 00:10 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 31 | $321.77 | $9,974.87 |
DisclosureSEC source: 0000059478-22-000190 · wf-form4_165827583473559.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 17:50 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 720 | $335.24 | $241,372.80 |
DisclosureSEC source: 0001209191-22-042380 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,966,500 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.20 to $335.33, inclusive. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 17:50 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 571 | $334.15 | $190,800.79 |
DisclosureSEC source: 0001209191-22-042380 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,967,220 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.9357 to $334.4811, inclusive. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 17:50 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 16,019 | $332.60 | $5,327,839.31 |
DisclosureSEC source: 0001209191-22-042380 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,967,791 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.50 to $333.34, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 16:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,428 | $332.23 | $806,642.30 |
DisclosureSEC source: 0001209191-22-041425 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,983,810 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.00 to $332.515, inclusive. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 16:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 43,875 | $331.33 | $14,536,884.38 |
DisclosureSEC source: 0001209191-22-041425 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,986,238 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $331.00 to $331.99, inclusive. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 16:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 52,138 | $330.42 | $17,227,594.37 |
DisclosureSEC source: 0001209191-22-041425 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,030,113 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.00 to $330.98, inclusive. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 16:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 78,802 | $329.54 | $25,968,174.67 |
DisclosureSEC source: 0001209191-22-041425 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,082,251 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.00 to $329.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| June 28, 2022 Filed Jun 29, 2022 15:31 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 900 | $329.01 | $296,109.00 |
DisclosureSEC source: 0001209191-22-039724 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,161,053 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.00 to $329.055, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 17:54 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 41,857 | $329.05 | $13,772,836.57 |
DisclosureSEC source: 0001209191-22-039569 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,161,953 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.00 to $329.78, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 17:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 5,263 | $325.61 | $1,713,680.17 |
DisclosureSEC source: 0001209191-22-039382 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,203,810 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.53 to $325.75, inclusive. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 17:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 113,470 | $324.97 | $36,874,345.90 |
DisclosureSEC source: 0001209191-22-039382 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,209,073 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.51 to $325.50, inclusive. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 17:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 51,387 | $324.12 | $16,655,348.89 |
DisclosureSEC source: 0001209191-22-039382 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,322,543 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.51 to $324.505, inclusive. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 17:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 30,081 | $323.06 | $9,717,907.70 |
DisclosureSEC source: 0001209191-22-039382 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,373,930 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.50 to $323.425, inclusive. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 17:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 14,799 | $321.98 | $4,765,041.22 |
DisclosureSEC source: 0001209191-22-039382 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,404,011 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.50 to $322.43, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 17:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 62 | $313.08 | $19,410.84 |
DisclosureSEC source: 0001209191-22-039153 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,418,810 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.07 to $313.08, inclusive. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 17:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 83,851 | $312.41 | $26,195,555.51 |
DisclosureSEC source: 0001209191-22-039153 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,418,872 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.00 to $312.99, inclusive. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 17:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 25,526 | $311.63 | $7,954,769.48 |
DisclosureSEC source: 0001209191-22-039153 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,502,723 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.00 to $311.995, inclusive. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 17:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 35,274 | $310.49 | $10,952,224.26 |
DisclosureSEC source: 0001209191-22-039153 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,528,249 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.00 to $310.9962, inclusive. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 17:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 60,287 | $309.23 | $18,642,790.16 |
DisclosureSEC source: 0001209191-22-039153 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,563,523 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.00 to $309.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4. Read SEC document |
| June 22, 2022 Filed Jun 23, 2022 18:50 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 9,119 | $309.19 | $2,819,467.13 |
DisclosureSEC source: 0001209191-22-038833 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,623,810 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.01 to $309.55, inclusive. Read SEC document |
| June 22, 2022 Filed Jun 23, 2022 18:50 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 18,603 | $308.27 | $5,734,709.60 |
DisclosureSEC source: 0001209191-22-038833 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,632,929 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $308.00 to $308.99, inclusive. Read SEC document |
| June 22, 2022 Filed Jun 23, 2022 18:50 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 67,330 | $307.35 | $20,693,740.84 |
DisclosureSEC source: 0001209191-22-038833 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,651,532 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.00 to $307.99, inclusive. Read SEC document |
| June 22, 2022 Filed Jun 23, 2022 18:50 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 80,923 | $306.33 | $24,789,142.59 |
DisclosureSEC source: 0001209191-22-038833 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,718,862 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.00 to $306.9934, inclusive. Read SEC document |
| June 22, 2022 Filed Jun 23, 2022 18:50 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 34,025 | $305.62 | $10,398,550.38 |
DisclosureSEC source: 0001209191-22-038833 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,799,785 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.00 to $305.9982, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 21:31 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 33 | $297.34 | $9,812.22 |
DisclosureSEC source: 0000059478-22-000165 · wf-form4_165593349399331.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 21:34 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 33 | $297.34 | $9,812.22 |
DisclosureSEC source: 0000059478-22-000167 · wf-form4_165593366397520.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 21:37 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 33 | $297.34 | $9,812.22 |
DisclosureSEC source: 0000059478-22-000169 · wf-form4_165593384044074.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,271 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 21:39 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 47 | $297.34 | $13,974.98 |
DisclosureSEC source: 0000059478-22-000171 · wf-form4_165593397653017.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,865 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 21:41 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 38 | $297.34 | $11,298.92 |
DisclosureSEC source: 0000059478-22-000173 · wf-form4_165593410349832.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,700 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 21:44 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 33 | $297.34 | $9,812.22 |
DisclosureSEC source: 0000059478-22-000175 · wf-form4_165593425122037.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,497 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:41 UTC |
Rau DiogoSVP & CIDO
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,560 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000161 · wf-form4_165420964136601.xml · derivative · entry 3 Rau Diogo · CIK 0001860253 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,600 Underlying: Common Stock · 7,560 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. F2 · derivative.expiration_date: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:41 UTC |
Rau DiogoSVP & CIDO
|
Tax withholdingCommon Stock | 3,166 | $313.44 | $992,351.04 |
DisclosureSEC source: 0000059478-22-000161 · wf-form4_165420964136601.xml · nonDerivative · entry 2 Rau Diogo · CIK 0001860253 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,394 Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:41 UTC |
Rau DiogoSVP & CIDO
|
Exercise / conversionCommon Stock | 7,560 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000161 · wf-form4_165420964136601.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:43 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 1,000 | $313.44 | $313,440.00 |
DisclosureSEC source: 0000059478-22-000163 · wf-form4_165420977657079.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,274 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021. Read SEC document |
| May 27, 2022 Filed May 31, 2022 18:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 17,143 | $323.42 | $5,544,406.20 |
DisclosureSEC source: 0001209191-22-032783 · doc4.xml · nonDerivative · entry 10 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,833,810 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.165 to $324.06, inclusive. Read SEC document |
| May 27, 2022 Filed May 31, 2022 18:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 8,400 | $322.51 | $2,709,109.20 |
DisclosureSEC source: 0001209191-22-032783 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,850,953 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.905 to $322.815, inclusive. Read SEC document |
| May 27, 2022 Filed May 31, 2022 18:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 11,262 | $321.27 | $3,618,142.74 |
DisclosureSEC source: 0001209191-22-032783 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,859,353 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.865 to $321.82, inclusive. Read SEC document |
| May 27, 2022 Filed May 31, 2022 18:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 25,542 | $320.11 | $8,176,351.79 |
DisclosureSEC source: 0001209191-22-032783 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,870,615 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.85 to $320.83, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.